Carlo Dufour, MD

Carlo Dufour works in G.Gaslini Research Children’s Hospital, Genova, Italy, the largest, multi specialist pediatric hospital of the country, where he chairs the Hemo-Onco- HSCT Department and the Hematology Unit where have seat the national Registry of Neutropenia, the national Registry of Alps and related disorders and  the national Data Base of Fanconi Anemia. He founded the Marrow Failure Syndromes Study Group within the Italian Pediatric Hemato- Oncology Association (AIEOP). He is author or co-author of  over 200 international publications and of various hematology textbook and text book chapters. He acts as reviewer for top ranking international journals including New England Journal of Medicine, Journal of Clinical Oncology, Leukemia, Clinical Immunology and Blood. He acted as Chairman of the Working Party of the Severe Aplastic Anemia (WPSAA) and as Board member of the European Society for Blood and Marrow Transplantation (EBMT). He currently serves as the chairman of  the Scientific Working Group on Granulocyte and Constitutional Marrow Failure Disorders of the European Hematology Association (EHA). Within EHA he is member of the  Guidelines Committee. In 2015 he  received by the Fanconi Anemia Research Fund. INC (FARF) the discovery award for participating to the identification of gene FANCT. Since  December 2019 is member of the Scientific Committee on Marrow Failures of the American Society of Hematology.
In December 2019 he was awarded for scientific contribution in Fanconi Anemia by the Spanish  “Fundacion en la Anemia de Fanconi”.  In august 2020 has been awarded by the EBMT along with Prof Regis Peffault de Latour and Prof Antonio Risitano, with the Van Bekkum award, a recognition reserved  to best scientific communication of the year, as Co PI of the prospective  randomized trial RACE ( Comparison of classical  IST ± Eltombopag) in Severe Aplastic Anemia.